GBA1 and Parkinson disease: Therefore, to fully understand protein biomarkers of PD and early PD, we next examined an unpublished LC–MS/MS proteomics study conducted in a separate group of participants from the PPMI cohort (PPMI 2) with a focus on carriers of GBA or LRRK2 mutations (Fig. 7a).